MEDICAL DEVICES

Cancer diagnostics and razor-blade business models

Pengana Capital

Pengana Capital Group

The New Criterion: tackling the asthma prevention market is no wheeze

Independent Investment Research

How to target a double-digit return

Monash Investors Pty Limited

Monash Investors Limited

Impedimed's two blue sky opportunities

Livewire Exclusive

Livewire Markets

Medtech Companies Gained 45.6% in FY15, And A Strong FY16 Expected

Canaccord Genuity

Stockbroker

Resmed trial disappoints, but thesis is intact

Morgans

Resmed tanks overnight on trial failure

Livewire Equities

Livewire